|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM152601163 |
003 |
DE-627 |
005 |
20231223062344.0 |
007 |
tu |
008 |
231223s2005 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed24n0509.xml
|
035 |
|
|
|a (DE-627)NLM152601163
|
035 |
|
|
|a (NLM)15596402
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Berger, Melvin
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Why HAE?
|
264 |
|
1 |
|c 2005
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 15.02.2005
|
500 |
|
|
|a Date Revised 16.11.2017
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Editorial
|
650 |
|
7 |
|a Complement C1 Inactivator Proteins
|2 NLM
|
650 |
|
7 |
|a Complement C1 Inhibitor Protein
|2 NLM
|
650 |
|
7 |
|a SERPING1 protein, human
|2 NLM
|
650 |
|
7 |
|a Serpins
|2 NLM
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 114(2005), 1 vom: 10. Jan., Seite 2
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:114
|g year:2005
|g number:1
|g day:10
|g month:01
|g pages:2
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 114
|j 2005
|e 1
|b 10
|c 01
|h 2
|